Announcements Trials

Browse Landscape

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 3 Sturge-Weber Syndrome 2 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Lennox Gastaut Syndrome 1 Glioblastoma 1 Epilepsy 1 Epilepsies, Myoclonic 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Breast Neoplasms 1 Arthralgia 1 Anxiety Disorders 1

Interventions

Sorafenib 52 pembrolizumab 26 Nivolumab 20 Bevacizumab 19 Radiosurgery 17 Doxorubicin 12 atezolizumab 9 Erlotinib Hydrochloride 9 lenvatinib 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 tremelimumab 6 durvalumab 6 Ramucirumab 6 Radiofrequency Ablation 6 Cisplatin 6 Sunitinib 5 tislelizumab 4 regorafenib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Fluorouracil 4 Everolimus 4 Capecitabine 4 nintedanib 3 fluoromisonidazole 3 carotuximab 3 bavituximab 3 Tomography, X-Ray Computed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Cannabidiol × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡